Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV

For HIV-infected children, formulation development, pharmacokinetic (PK) data, and evaluation of early toxicity are critical for licensing new antiretroviral drugs; direct evidence of efficacy in children may not be needed if acceptable safety and PK parameters are demonstrated in children. However,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Acquir Immune Defic Syndr
Main Authors: Ford, Deborah, Turner, Rebecca, Turkova, Anna, Penazzato, Martina, Musiime, Victor, Bwakura-Dangarembizi, Mutsa, Violari, Avy, Chabala, Chishala, Puthanakit, Thanyawee, Sudjaritruk, Tavitiya, Cressey, Tim R., Lallemant, Marc, Gibb, Diana M.
Formato: Artigo
Idioma:Inglês
Publicado em: JAIDS Journal of Acquired Immune Deficiency Syndromes 2018
Assuntos:
Supplement Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071856/
https://ncbi.nlm.nih.gov/pubmed/29994919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001748
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados